Tuberculosis in childhood

Therapeutic Advances in Respiratory Disease

Volumn 6, Issue 3, 2012, Pages 161-171

  Shingadia, Delane ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

child; diagnosis; treatment; tuberculosis

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMINOTRANSFERASE; AZITHROMYCIN; BEDAQUILINE; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ABDOMINAL PAIN; AMINOTRANSFERASE BLOOD LEVEL; BACTERIUM CULTURE; CHILD; CHILDHOOD DISEASE; DIAGNOSTIC TEST; DIRECTLY OBSERVED THERAPY; DISEASE TRANSMISSION; DRUG FATALITY; EXTRAPULMONARY TUBERCULOSIS; HEALTH PROGRAM; HILAR ADENOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT TUBERCULOSIS; LIVER DYSFUNCTION; LIVER TOXICITY; LUNG TUBERCULOSIS; LYMPHADENOPATHY; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; NONHUMAN; PATIENT COMPLIANCE; PERICARDIAL EFFUSION; PLEURA EFFUSION; POPULATION MIGRATION; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; RASH; RECOMMENDED DRUG DOSE; RETROBULBAR OPTIC NEUROPATHY; REVIEW; SERODIAGNOSIS; SHORT COURSE THERAPY; SIDE EFFECT; STAINING; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT INDICATION; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS MENINGITIS; VOMITING;

ADULT; AGE FACTORS; ANTITUBERCULAR AGENTS; CHILD; DIRECTLY OBSERVED THERAPY; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; MEDICATION ADHERENCE; NATIONAL HEALTH PROGRAMS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84861874438     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753465812436662     Document Type: Article

References (72)

1. Abadco D. Steiner P. (1993) Gastric lavage is better than bronchoalveolar lavage for isolation of Mycobacterium tuberculosis in childhood tuberculosis. Pediatr Infect Dis J 11: 735–738.
2. Al-Dossary F. Ong L. Correa A. Starke J. (2002) Treatment of childhood tuberculosis using a 6-month, directly observed regimen with only 2 weeks of daily therapy. Pediatr Infect Dis J 21: 91–97.
3. Andronikou S. Joseph E. Lucas S. Brachmeyer S. Du Toit G. Zar H. (2004) CT scanning for the detection of tuberculous mediastinal and hilar lymphadenopathy in children. Pediatr Radiol 34: 232–236.
4. Ba F. Rieder H. (1999) A comparison of fluorescence microscopy with the Ziehl-Neelsen technique in the examination of sputum for acid-fast bacilli. Int J Tuberc Lung Dis 3: 1101–1105.
5. Biddulph J. (1990) Short course chemotherapy for childhood tuberculosis. Pediatr Infect Dis J 9: 794–801.
6. Blyth C. Waring J. Burgner D. (2004) Inconspicuous consumption: disseminated tuberculosis following untreated latent infection. J Paediatr Child Health 40: 227–229.
7. Bright-Thomas R. Nandwani S. Smith J. Morris J. Ormerod L. (2010) Effectivenes of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children. Arch Dis Child. 95: 600–602.
8. Cantwell M. Binkin N. (1997) Impact of HIV on tuberculosis in sub-Saharan Africa: a regional perspective. Int J Tuberc Lung Dis 1: 205–214.
9. Curry F. J. (1967) Prophylactic effect of isoniazid in young tuberculin reactors. N Engl J Med 277: 562–567.
10. De Backer A. Mortele K. Vanhoenacker F. Parizel P. (2006) Imaging of extraspinal musculoskeletal tuberculosis. Eur J Radiol 57: 119–130.
11. Diacon A. Pym A. Grobusch M. Patientia R. Rustomjee R. Page-Shipp L. (2009) The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 360: 2397–2405.
12. Eisenach K. Sifford M. Cane M. Bates J. Crawford J. (1991) Detection of mycobacterium tuberculosis in sputum samples using a polymerase chain reaction. Am Rev Resp Dis. 144: 1160–1163.
13. Ena J. Valls V. (2005) Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis. 40: 670–676.
14. Farinha N. Razali K. Holzel H. Morgan G. Novelli V. (2000) Tuberculosis of the central nervous system in children: a 20-year survey. J Infect 41: 61–68.
15. Fauville-Dufaux M. Waelbroeck A. Mol P. Vanfleteren B. Levy J. Debusschere P. Farber C. (1996) Contribution of the polymerase chain reaction to the diagnosis of tuberculous infection in children. Eur J Pediatr 155: 106–111.
16. Girgis N. Farid Z. Kilpatrick M. (1991) Dexamethasone as an adjunct to treatment of tuberculous meningitis Pediatr Infect Dis J 10: 179.
17. Gomez-Pastrana D. Torronteras R. Caro P. Anguita M. Barrio A. Andres A. Navarro J. (1999) Diagnosis of tuberculosis in children using a polymerase chain reaction. Pediatr Pulmonol 28: 344–351.
18. Haas D. W. (2000). Mycobacterium tuberculosis. In Mandell G.L. Bennett J.E. Dolin R. (eds) Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, pp. 2576–607.
19. Harris V. Dida F. Lander S. (1977) Cavitary tuberculosis in children. J Pediatr 90: 660–661.
20. Hershfield E. (1991) Tuberculosis in children: guidelines for diagnosis, prevention and management (a statement of the scientific committees of the IUATLD) Bull World Health Organ 66: 61–67.
21. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council (1992). A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 145: 36–41.
22. Hsu K. (1983) Tuberculin reaction in children treated with isoniazid. Am J Dis Child 137: 1090–1092.
23. Ijaz K. Jereb J. A. Lambert L. A. Bower W. A. Spradling P. R. McElroy P. D. Iademarco M. F. (2006) Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infection. Clin Infect Dis 42: 346–355.
24. Jacobs R. Abernathy R. (1985) The treatment of tuberculosis in children. Pediatr Infect Dis J. 4: 513–517.
25. Jacobs R. Starke J. (1993) Tuberculosis in children. Med Clin North Am. 77: 1335–1351.
26. Janssens J. deHaller R. (1990) Spinal tuberculous in a developed country. Clin Orthop. 256: 67.
27. Khan E. Starke J. (1995) Diagnosis of tuberculosis in children: increased need for better methods. Emerg Infect Diseases. 1: 115–123.
28. Kumar D. Watson J. Charlett A. (1997) Tuberculosis in England and Wales in 1993: results of a national survey. Thorax. 52: 1060–1067.
29. Kumar L. Dhand R. Singhi P. Rao K. Katariya S. (1990) A randomized trial of fully intermittent vs daily followed by intermittent short course chemotherapy for childhood tuberculosis. Pediatr Infect Dis J. 9: 802–806.
30. Lalvani A. Nagvenkar P. Udwadia Z. Pathan A. Wilkinson K. Shastri J. (2001) Enumeration of T cells specific for RDi-encoded antigens suggest a high prevalence of latent mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis. 183: 469–477.
31. Larsson L. Bentzon M. Lind A. Magnusson M. Sandegard G. Skoogh B. (1993) Sensitivity to senstins and tuberculin in Swedish Children. Part 5: A study of school children in an inland rural area. Tuber Lung Dis 74: 371–376.
32. Lincoln E. Gilbert L. Morales S. (1960) Chronic pulmonary tuberculosis in individuals with known previous tuberculosis. Dis Chest. 38: 473.
33. Ling D. Zwerling A. Steingart K. Pai M. (2011) Immune-based diagnostics for TB in children: what is the evidence? Paediatr Resp Rev. 12: 9–15.
34. Lonnroth K. Castro K. Chakaya J. Chauhan L. Floyd K. Glaziou P. (2010) Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 375: 1814–1829.
35. Marais B. Brittle W. Painczyk K. Hesseling A. C. Beyers N. Wasserman E. (2008) Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clin Infect Dis. 47: 203–207.
36. Marais B.J. Gie R.P. Obihara C.C. Hesseling A.C. Schaaf H.S. Beyers N. (2005) Well defined symptoms are of value in the diagnosis of childhood pulmonary tuberculosis. Arch Dis Child. 90: 1162–1165.
37. McElroy P.D. Ijaz K. Lambert L.A. Jereb J.A. Iademarco M.F. Castro K.G. (2005) National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection. Clin Infect Dis 41: 1125–33.
38. Miller F.J.M. Seale R.M.E. Taylor N.M. (1963) Tuberculosis in children. Boston: Little Brown.
39. National Collaborating Centre for Chronic Conditions. (2006) Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians.
40. Nemir R. Cordova J. Vaziri F. (1967) Prednisone as an adjunct in the chemotherapy of lymph node-bronchial tuberculosis in childhood: a double-blinded study. Am Rev Respir Dis 95: 402.
41. Nemir R. Krasinski K. (1988) Tuberculosis in children and adolescents in the 1980s. Pediatr Infect Dis J 7: 375–379.
42. Nicol M. Zar H. (2011) New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatr Respir Rev 12: 16–21.
43. Noordhock A. Kolk A. Bjune G. (1994) Sensitivity and specificity of polymerase chain reaction for detection of mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol 32: 277–284.
44. Pickering L. Baker C. Kimberlin D. Long S. (Eds.) American Academy of Pediatrics (2009) Red Book: 2009 Report of the Committee on Infectious Diseases. American Academy of Pediatrics: Elk Grove Village.
45. Raviglione M. Snider D. Kochi A. (1995) Global epidemiology of tuberculosis JAMA 273: 220–226.
46. Reichman L. B. Lardizabal A. Hayden C. H. (2004) Considering the role of four months of rifampin in the treatment of latent tuberculosis infection. Am J Respir Crit Care Med 170: 832–835.
47. Reis F. Bedran M. Moura J. Assis I. Rodrigues M. (1990) Six-month isoniazid-rifampicin treatment for pulmonary tuberculosis in children. Am Rev Respir Dis 142: 996–999.
48. Schoeman J. Van Zyl L. Laubscher J. Donald P. (1997) Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome with tuberculous meningitis. Pediatrics. 99: 226–231.
49. Sepulveda R. Burr C. Ferrer X. Sorensen R. (1988) Booster effect of tuberculin testing in healthy 6-yearpold school children vaccinated with bacille Calmette-Guerin at birth in Santiago, Chile. Pediatr Infect Dis J. 7: 578–582.
50. Smieja M.J. Marchetti C.A. Cook D.J. Smaill F.M. (2000) Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev: CD001363.
51. Smith K. Starke J. Eisenach K. Ong L. Denby M. (1996) Detection of Mycobacterium tuberculosis in clinical specimens from children using a polymerase chain reaction. Pediatrics. 97: 155–160.
52. Somu N. Swaminathan S. Paramasivan C. Vijayasekeran D. Chandrabhooshanam A. Vijaysn V. (1995) Value of bronchoalveolar lavage and gastric lavage in the diagnosis of pulmonary tuberculosis in children. Tuber Lung Dis 76: 295–299.
53. Starke J. Ong L. Eisenach K. (1993) Detection of M. tuberculosis in gastric aspirate samples from children using polymerase chain reaction. Am Rev Respir Dis 147: A801.
54. Starke J. Taylor-Watts K. (1989) Tuberculosis in the pediatric population of Houston, Texas. Pediatrics 84: 28–35.
55. Steingart K. Henry M. Ng V. Hopewell P. Ramsay A. Cunningham J. (2006) Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 6: 570–581.
56. Strumpf I. Tsang A. Syre J. (1979) Re-evaluation of sputum staining for the diagnosis of pulmonary tuberculosis. Am Rev Respir Dis 119: 599–602.
57. Swaminathan S. Rekha B. (2010) Pediatric tuberculosis: global overview and challenges. Clin Infect Dis 50: S184–194.
58. Swingler G. Du Toit G. Andronikou S. van der Merwe L. Zar H. (2005) Diagnostic accuracy of chest radiography in detecting mediastinal lymphadenopathy in suspected pulmonary tuberculosis Arch Dis Child 90: 1153–1156.
59. te Water Naude J. Donald P. Hussey G. Kibel M. Louw A. Perkins D. Shaaf H. (2000) Twice weekly vs. daily cheotherapy for childhood tuberculosis. Pediatr Infect Dis J 19: 405–410.
60. Trebucq A. (1997) Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature. Int J Tuberc Lung Dis 1: 12–15.
61. Tsakalidis D. Pratsidou P. Hitoglou-Makedou A. Tzouvelekis G. Sofroniadis I. (1992) Intensive short course chemotherapy for treatment of Greek children with tuberculosis. Pediatr Infect Dis J 11: 1036–1042.
62. Ussery X. Valway S. McKenna M. (1996) Epidemiology of tuberculosis among children in the United States. Pediatr Infect Dis J 15: 697–704.
63. Vallejo J. Ong L. Starke J. (1994) Clinical features, diagnosis and treatment of tuberculosis in infants. Pediatrics 94: 1–7.
64. Varudkar B. (1985) Short course chemotherapy for tuberculosis in children. Indian J Pediatr 52: 593–597.
65. Watterson S. Drobniewski F. (2000) Modern laboratory diagnosis of mycobacterial infections. J Clin Pathol. 53: 727–732.
66. WHO (1982) Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ 60: 555–564.
67. World Health Organization. (1994) WHO tuberculosis programme framework for effective tuberculosis control. Geneva: WHO, pp. 179.
68. World Health Organization. (1997) Treatment of tuberculosis: guidelines for national programmes. Geneva: WHO
69. World Health Organization. (2009) Global Tuberculosis control: epidemiology, strategy, financing. Geneva: WHO
70. World Health Organization. (2010) Rapid Advice. Treatment of tuberculosis in children. Geneva: WHO
71. World Health Organization. (1989) Expanded Program on Immunization. Update. Geneva: WHO
72. Zar H. Tannenbaum E. Apolles P. Roux P. Hanslo D. Hussey G. (2000) Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa. Arch Dis Child 82: 305–308.